文献速递病毒性肝炎细菌感染、耐药与抗菌药物

需免疫抑制治疗的HBV感染者中HBV再激活的特征、预防与管理

Characteristics, Prevention, and Management of Hepatitis B Virus (HBV) Reactivation in HBV-Infected Patients Who Require Immunosuppressive Therapy.
PubMed 文献 · J Infect Dis · 2017-01-01

本文综述了在接受免疫抑制剂或细胞毒性化疗的HBV感染者中,HBV再激活可从无症状到致命性肝衰竭,并可影响原发病治疗与生存。文章总结了再激活的诊断标准与临床结局,讨论了免疫抑制治疗如何影响再激活风险,并提出了预防策略。

要点

  • 免疫抑制治疗前应筛查HBV再激活风险。
  • 再激活谱从无症状到肝衰竭死亡,可影响原发病预后。
  • 预防性抗病毒治疗可预防和管理HBV再激活。

核心结论

  • HBV再激活可预防和管理,前提是筛查风险并在免疫抑制治疗前预防性治疗。

研究设计与样本

  • 综述,检索范围未报告。

主要发现

  • HBV再激活谱从无症状再激活到肝衰竭导致死亡。
  • 再激活可妨碍计划治疗进程并削弱疗效, adversely影响原发病预后和患者生存。

关键数值与推荐

  • 文中汇总了HBV再激活的诊断标准和临床结局。
  • 文中讨论了免疫抑制治疗对HBV再激活风险的影响。

临床怎么用

  • 对需免疫抑制剂或细胞毒性化疗的患者,应筛查HBV再激活风险。
  • 对高风险患者,应在治疗开始前进行预防性抗病毒治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hepatitis B virus (HBV) reactivation becomes a challenging issue with increasing use of immunosuppressive agents and cytotoxic chemotherapy for varied medical conditions, including cancer. The spectrum of HBV reactivation in the setting of immunosuppression may vary from asymptomatic reactivation to liver failure leading to death. HBV reactivation can hamper the course of planned therapies and diminish the effects of therapies; thus, it adversely affects the prognosis of the original disease and the survival of the patients. There is mounting evidence that HBV reactivation can be prevented and managed if patients are screened to determine their risk for HBV reactivation and are treated prophylactically before therapy with immunosuppressive agents or cytotoxic chemotherapy is initiated. In this article, we review the diagnostic criteria and clinical outcomes of HBV reactivation, discuss how immunosuppressive therapy may influence the risk of HBV reactivation, and outline strategies to prevent HBV reactivation.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Choi J, Lim YS. Characteristics, Prevention, and Management of Hepatitis B Virus (HBV) Reactivation in HBV-Infected Patients Who Require Immunosuppressive Therapy. J Infect Dis. 2017. PMID: 29156044. doi:10.1093/infdis/jix178

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。